InvestorsHub Logo
Post# of 252302
Next 10
Followers 36
Posts 3185
Boards Moderated 0
Alias Born 10/18/2003

Re: DFRAI post# 188024

Monday, 03/02/2015 1:38:20 PM

Monday, March 02, 2015 1:38:20 PM

Post# of 252302
The proportion of patients with 3 lines of vision is the more important endpoint.

I know of Ophthotech having some vision improvement in a randomized trial vs lucentis. Are the other drugs you mention in placebo controlled trials or open label?

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.